Compare CORT & ONB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CORT | ONB |
|---|---|---|
| Founded | 1998 | 1834 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.2B |
| IPO Year | 2001 | 2012 |
| Metric | CORT | ONB |
|---|---|---|
| Price | $113.05 | $25.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 12 |
| Target Price | ★ $96.50 | $27.25 |
| AVG Volume (30 Days) | 805.4K | ★ 3.1M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.46% |
| EPS Growth | N/A | ★ 6.55 |
| EPS | 0.09 | ★ 0.59 |
| Revenue | ★ $761,407,000.00 | $125,616,000.00 |
| Revenue This Year | $26.08 | $27.93 |
| Revenue Next Year | $26.98 | $5.10 |
| P/E Ratio | $1,259.44 | ★ $43.36 |
| Revenue Growth | ★ 12.79 | 6.07 |
| 52 Week Low | $28.66 | $19.39 |
| 52 Week High | $126.38 | $27.36 |
| Indicator | CORT | ONB |
|---|---|---|
| Relative Strength Index (RSI) | 51.71 | 32.18 |
| Support Level | $77.73 | $24.04 |
| Resistance Level | $122.21 | $25.47 |
| Average True Range (ATR) | 4.04 | 0.43 |
| MACD | -1.68 | -0.14 |
| Stochastic Oscillator | 15.22 | 1.80 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Old National Bancorp is a provider of lending and deposit services. The bank offers comprehensive wealth management, trust, investment advisory, brokerage, and foreign currency services. For businesses, it provides treasury management, merchant, and capital markets services as well as community development lending and equity investment solutions intended to produce jobs and revitalize its communities. It earns interest income on loans as well as fee income from the origination of loans and from providing other services to its clients.